IP Library Granted Patent US 8,779,170
Granted Patent B2
US 8,779,170 · App. 13/524,568 · Granted Jul 15, 2014

Method of producing beraprost

Inventors: Vijay Sharma (Olney, MD); Hitesh Batra (Herndon, VA); Sudersan Tuladhar (Silver Spring, MD)
Assignee: Lung Biotechnology Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,779,170
App. No.
13/524,568
Granted
Jul 15, 2014
Kind
B2
Abstract

An improved method is described for making single isomers of synthetic benzoprostacyclin analogue compounds, in particular the pharmacologically active 314-d isomer of beraprost. In contrast to the prior art, the method is stereoselective and requires fewer steps than the known methods for making these compounds.

Claims (21)

1. A process for preparing a compound of the following formula:

wherein R 1 represents a cation, H, or C 1-12 alkyl,

R 2 and R 3 each represent H or a hydroxy protective group,

R 4 represents H or C 1-3 alkyl, and

R 5 represents H or C 1-6 alkyl, comprising the steps of:

(1) performing a cycloaddition reaction on the compound of the following formula:

wherein in R 2a and R 6 independently represent hydroxy protecting groups,

with a compound of the following formula:

wherein R 7 represents C 1-6 alkoxy or C 1-12 alkyl-COOR 9 , where R 9 represents C 1-3 alkyl and R 8 represents halide or H to form a compound of the following formula:

wherein R 2a , R 6 , R 7 , and R 8 are each defined above;

(2) aromatizing the cyclodiene of formula (IV) to form the aromatic product of the following formula:

(3) Reducing the ester of the compound of formula (V) to a benzyl alcohol and oxidation of benzyl alcohol to an aldehyde followed by addition of a carbon to said aldehyde to form an alkyne resulting in a compound of the following formula:

(4) coupling the terminal alkyne with N 2 CH 2 CO 2 R 1a , wherein R 1a represents a C 1-12 alkyl followed by hydrogenation of the alkyne to its corresponding alkane to form a compound of the following formula:

(5) selectively deprotecting the primary hydroxyl protective group, followed by oxidation of the primary hydroxyl group to the corresponding aldehyde, followed by coupling with a side-chain of the formula:

wherein R 4 and R 5 are each defined above to form a compound of the following formula:

(6) reduction of the ketone, deprotection of any remaining hydroxy protective group and optionally converting the R 1a into a cation or H to form a compound of the following formula:

2. The process of claim 1 , wherein the compound of formula (I) is produced as a substantially pure single isomer.

3. The process of claim 1 , wherein R 1 is a cation or H, R 2 and R 3 are H, R 4 and R 5 are CH 3 .

4. The process of claim 1 , wherein R 2 , R 3 , R 2a and R 6 each independently represent trimethylsilyl, triethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, phenyldimethylsilyl, or tetrahydropyranyl.

5. The process of claim 1 , wherein the cycloaddition of step (1) is an inverse electron demand Diels Alder reaction followed by thermal decarboxylation.

6. The process of claim 1 , wherein the aromatization step (2) is treatment of the compound of formula (IV) with palladium on carbon.

Assignments (3)
CHANGE OF NAME Recorded May 5, 2015
From: LUNG BIOTECHNOLOGY INC.
To: LUNG BIOTECHNOLOGY PBC
Reel/Frame 035574/0927 →
CHANGE OF NAME Recorded Apr 21, 2014
From: LUNG LLC
To: LUNG BIOTECHNOLOGY INC.
Reel/Frame 032722/0534 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2012
From: SHARMA, VIJAY, DR.; BATRA, HITESH, DR.; TULADHAR, SUDERSAN, DR.
To: LUNG LLC
Reel/Frame 028867/0417 →
Continuity (2)
Provisional Application 61497754 · Jun 16, 2011
Related Publication 20120323025A1 · Dec 20, 2012